Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Positive results in Panacos’ HIV drug trial
The study met its primary endpoint by demonstrating a statistically significant reduction in the level of HIV in the blood, known as viral load, compared to placebo. The
The study met its primary endpoint by demonstrating a statistically significant reduction in the level of HIV in the blood, known as viral load, compared to placebo. The
“Currently ischemic brain damage (brain damage caused by a lack of blood to the brain) is found in 80% of patients who die of severe head injury,” said
OSI will acquire all outstanding shares of Eyetech common stock at a price of $20 per share in a combination of cash and OSI common stock, representing a
Merck & Co. has been ordered to pay the widow of Robert Ernst $253.4 million in damages. Although these costs are expected to be reduced to 10% of
The findings gained from experiments in which monkeys were given a chance to gamble to receive juice rewards, could give insights into why humans compulsively engage in risky
The study, commissioned by the UK Department of Health, will look at the detection of colonization by MRSA (methicillin-resistant Staphylococcus aureus) in UK patients based at NHS Trusts
The University hopes to hire 15 scientists in heart and vascular diseases, diabetes and obesity, neurobiology and respiratory biology. The new researchers will be expected to work toward
The head-to-head study of two of the most widely used chemotherapy agents in breast cancer shows a significantly increased overall survival of 15.4 months for those patients who
Researchers from the University of Oslo compiled data from 16 studies (some unpublished) comparing the use of Paxil (paroxetine) with placebo for its connection to suicide attempts, concluded
The application, which was filed on schedule, includes clinical data from a previously announced phase III trial demonstrating superiority of anidulafungin versus fluconazole in invasive candidiasis/candidemia. Anidulafungin is